Targeting of Alpha-V Integrins Reduces Malignancy of Bladder Carcinoma

Open Access

Peer-reviewed

Research Article

Geertje van der Horst ,

* E-mail: G.van_der_Horst@lumc.nl

Affiliation Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands
⨯
Lieke Bos,

Affiliation Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands
⨯
Maaike van der Mark,

Affiliation Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands
⨯
Henry Cheung,

Affiliation Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands
⨯
Bertrand Heckmann,

Affiliation Galapagos SASU, Romainville, France
⨯
Philippe Clément-Lacroix,

Affiliation Galapagos SASU, Romainville, France
⨯
Giocondo Lorenzon,

Affiliation Galapagos SASU, Romainville, France
⨯
Rob C. M. Pelger,

Affiliation Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands
⨯
Rob F. M. Bevers,

Affiliation Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands
⨯
Gabri van der Pluijm

Affiliation Department of Urology, Leiden University Medical Centre, Leiden, The Netherlands
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Bladder cancer
Is the Subject Area "Bladder cancer" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Integrins
Is the Subject Area "Integrins" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cloning
Is the Subject Area "Cloning" applicable to this article?

Thanks for your feedback.
Protein expression
Is the Subject Area "Protein expression" applicable to this article?

Thanks for your feedback.